Worcester Polytechnic Institute (WPI) researcher Zhenglun “Alan” Wei is aiming to improve prenatal diagnosis of the most common cardiac birth defect by going with the flow … of blood in tiny hearts.

Zhenglun "Alan" Wei
Wei, an assistant professor in the Department of Biomedical Engineering, is leading a four-year project funded with $2,915,519 from the National Institutes of Health to develop a personalized model that will use detailed blood flow information collected from noninvasive tests to detect obstructions of the aorta in fetuses.
The project aims to improve prenatal testing so that doctors can spot problems in the aorta, a large blood vessel that carries oxygen-rich blood from the heart to the body, before a baby is born and recommend treatments. Current testing relies on anatomic information, rather than blood-flow data, to assess fetal heart health.
“Standard prenatal testing and even specialized imaging often fail to detect anatomical problems in the fetal aorta,” Wei says. “By integrating detailed blood flow parameters, we will give doctors a more precise tool to use when diagnosing congenital heart defects.”
Wei is working on the project with Professor Zhongqiang Zhang and Associate Professor Fangfang Wang, both of WPI’s Department of Mathematical Sciences, and Dr. Shuping Ge, a pediatric cardiologist and researcher with the Geisinger healthcare system in Pennsylvania. The researchers are focusing on a specific condition called coarctation of the aorta, which involves a narrowing, or pinch, in the aorta as it leaves the heart.
Coarctation of the aorta restricts blood flow to the body and forces the heart to work harder to pump blood. The condition accounts for an estimated 6% to 8% of all cardiac birth defects.
Diagnosing coarctation of the aorta, especially before birth, can be challenging. Standard ultrasound testing and specialized echocardiograms, noninvasive tests that use sound waves to create images and generate data about a fetus, often fail to detect anatomical and blood flow abnormalities in a developing heart. In addition, ultrasound-based tests sometimes falsely suggest that an abnormality is present even when no such defect exists.